+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Preclinical Software for Physiology Data Assessment and Animal Supervision Market 2024-2028

  • PDF Icon

    Report

  • 161 Pages
  • January 2024
  • Region: Global
  • TechNavio
  • ID: 5174381
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The preclinical software for physiology data assessment and animal supervision market is forecasted to grow by USD 3.92 bn during 2023-2028, accelerating at a CAGR of 5.62% during the forecast period. The report on the preclinical software for physiology data assessment and animal supervision market provides a holistic analysis, market size, and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the emerging role of bioinformatics tools and software in preclinical research, increasing awareness of physiological monitoring in preclinical research, and increasing use of animals in preclinical studies.

The preclinical software for physiology data assessment and animal supervision market is segmented as below:

By End-user

  • Industrial labs and CROs
  • Academic, government, and research labs

By Deployment

  • On-premises
  • Cloud

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rising digitalization in preclinical research as one of the prime reasons driving the preclinical software for physiology data assessment and animal supervision market growth during the next few years. Also, increasing outsourcing of preclinical research and growing demand for send submission software for preclinical data will lead to sizable demand in the market.

The report on the preclinical software for physiology data assessment and animal supervision market covers the following areas:

  • Preclinical software for physiology data assessment and animal supervision market sizing
  • Preclinical software for physiology data assessment and animal supervision market forecast
  • Preclinical software for physiology data assessment and animal supervision market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading preclinical software for physiology data assessment and animal supervision market vendors that include ADInstruments Pty Ltd., BIOPAC Systems Inc., Bruker Corp., Columbus Instruments LLC, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Instem Plc, Med Associates Inc., Noldus Information Technology bv, PerkinElmer Inc, Starr Life Sciences Corp., Stoelting Co., Thermo Fisher Scientific Inc., TSE Systems GmbH, UGO BASILE S.R.L., Vanderbilt University Medical Center, Xybion Digital Inc., and Zaber Technologies Inc.. Also, the preclinical software for physiology data assessment and animal supervision market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and an analysis of the key vendors.

The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Deployment
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global preclinical software for physiology data assessment and animal supervision market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global preclinical software for physiology data assessment and animal supervision market 2018 - 2022 ($ billion)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.3 Deployment Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Deployment Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Industrial labs and CROs - Market size and forecast 2023-2028
Exhibit 34: Chart on Industrial labs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Industrial labs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Industrial labs and CROs - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Industrial labs and CROs - Year-over-year growth 2023-2028 (%)
6.4 Academic, government, and research labs - Market size and forecast 2023-2028
Exhibit 38: Chart on Academic, government, and research labs - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Academic, government, and research labs - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Academic, government, and research labs - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Academic, government, and research labs - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by End-user
Exhibit 42: Market opportunity by End-user ($ billion)
Exhibit 43: Data Table on Market opportunity by End-user ($ billion)
7 Market Segmentation by Deployment
7.1 Market segments
Exhibit 44: Chart on Deployment - Market share 2023-2028 (%)
Exhibit 45: Data Table on Deployment - Market share 2023-2028 (%)
7.2 Comparison by Deployment
Exhibit 46: Chart on Comparison by Deployment
Exhibit 47: Data Table on Comparison by Deployment
7.3 On-premises - Market size and forecast 2023-2028
Exhibit 48: Chart on On-premises - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on On-premises - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on On-premises - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on On-premises - Year-over-year growth 2023-2028 (%)
7.4 Cloud - Market size and forecast 2023-2028
Exhibit 52: Chart on Cloud - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Cloud - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Cloud - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Cloud - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Deployment
Exhibit 56: Market opportunity by Deployment ($ billion)
Exhibit 57: Data Table on Market opportunity by Deployment ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 83: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 France - Market size and forecast 2023-2028
Exhibit 91: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on France - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Exhibit 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ billion)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 ADInstruments Pty Ltd.
Exhibit 107: ADInstruments Pty Ltd. - Overview
Exhibit 108: ADInstruments Pty Ltd. - Product/Service
Exhibit 109: ADInstruments Pty Ltd. - Key offerings
12.4 BIOPAC Systems Inc.
Exhibit 110: BIOPAC Systems Inc. - Overview
Exhibit 111: BIOPAC Systems Inc. - Product/Service
Exhibit 112: BIOPAC Systems Inc. - Key offerings
12.5 Bruker Corp.
Exhibit 113: Bruker Corp. - Overview
Exhibit 114: Bruker Corp. - Business segments
Exhibit 115: Bruker Corp. - Key offerings
Exhibit 116: Bruker Corp. - Segment focus
12.6 Columbus Instruments LLC
Exhibit 117: Columbus Instruments LLC - Overview
Exhibit 118: Columbus Instruments LLC - Product/Service
Exhibit 119: Columbus Instruments LLC - Key offerings
12.7 emka TECHNOLOGIES
Exhibit 120: emka TECHNOLOGIES - Overview
Exhibit 121: emka TECHNOLOGIES - Product/Service
Exhibit 122: emka TECHNOLOGIES - Key offerings
12.8 ETISENSE SAS
Exhibit 123: ETISENSE SAS - Overview
Exhibit 124: ETISENSE SAS - Product/Service
Exhibit 125: ETISENSE SAS - Key offerings
12.9 Harvard Bioscience Inc.
Exhibit 126: Harvard Bioscience Inc. - Overview
Exhibit 127: Harvard Bioscience Inc. - Product/Service
Exhibit 128: Harvard Bioscience Inc. - Key offerings
12.10 Instem Plc
Exhibit 129: Instem Plc - Overview
Exhibit 130: Instem Plc - Product/Service
Exhibit 131: Instem Plc - Key offerings
12.11 Med Associates Inc.
Exhibit 132: Med Associates Inc. - Overview
Exhibit 133: Med Associates Inc. - Product/Service
Exhibit 134: Med Associates Inc. - Key offerings
12.12 Noldus Information Technology bv
Exhibit 135: Noldus Information Technology bv - Overview
Exhibit 136: Noldus Information Technology bv - Product/Service
Exhibit 137: Noldus Information Technology bv - Key offerings
12.13 PerkinElmer Inc
Exhibit 138: PerkinElmer Inc - Overview
Exhibit 139: PerkinElmer Inc - Business segments
Exhibit 140: PerkinElmer Inc - Key news
Exhibit 141: PerkinElmer Inc - Key offerings
Exhibit 142: PerkinElmer Inc - Segment focus
12.14 Starr Life Sciences Corp.
Exhibit 143: Starr Life Sciences Corp. - Overview
Exhibit 144: Starr Life Sciences Corp. - Product/Service
Exhibit 145: Starr Life Sciences Corp. - Key offerings
12.15 Stoelting Co.
Exhibit 146: Stoelting Co. - Overview
Exhibit 147: Stoelting Co. - Product/Service
Exhibit 148: Stoelting Co. - Key offerings
12.16 TSE Systems GmbH
Exhibit 149: TSE Systems GmbH - Overview
Exhibit 150: TSE Systems GmbH - Product/Service
Exhibit 151: TSE Systems GmbH - Key offerings
12.17 Xybion Digital Inc.
Exhibit 152: Xybion Digital Inc. - Overview
Exhibit 153: Xybion Digital Inc. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 154: Inclusions checklist
Exhibit 155: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 156: Currency conversion rates for US$
13.4 Research methodology
Exhibit 157: Research methodology
Exhibit 158: Validation techniques employed for market sizing
Exhibit 159: Information sources
13.5 List of abbreviations
Exhibit 160: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits 6: Executive Summary - Chart on Market Segmentation by Deployment
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 18: Historic Market Size - Data Table on global preclinical software for physiology data assessment and animal supervision market 2018 - 2022 ($ billion)
Exhibits 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits 20: Historic Market Size - Deployment Segment 2018 - 2022 ($ billion)
Exhibits 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits 23: Five forces analysis - Comparison between 2023 and 2028
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 29: Chart on Market condition - Five forces 2023 and 2028
Exhibits 30: Chart on End-user - Market share 2023-2028 (%)
Exhibits 31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits 32: Chart on Comparison by End-user
Exhibits 33: Data Table on Comparison by End-user
Exhibits 34: Chart on Industrial labs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibits 35: Data Table on Industrial labs and CROs - Market size and forecast 2023-2028 ($ billion)
Exhibits 36: Chart on Industrial labs and CROs - Year-over-year growth 2023-2028 (%)
Exhibits 37: Data Table on Industrial labs and CROs - Year-over-year growth 2023-2028 (%)
Exhibits 38: Chart on Academic, government, and research labs - Market size and forecast 2023-2028 ($ billion)
Exhibits 39: Data Table on Academic, government, and research labs - Market size and forecast 2023-2028 ($ billion)
Exhibits 40: Chart on Academic, government, and research labs - Year-over-year growth 2023-2028 (%)
Exhibits 41: Data Table on Academic, government, and research labs - Year-over-year growth 2023-2028 (%)
Exhibits 42: Market opportunity by End-user ($ billion)
Exhibits 43: Data Table on Market opportunity by End-user ($ billion)
Exhibits 44: Chart on Deployment - Market share 2023-2028 (%)
Exhibits 45: Data Table on Deployment - Market share 2023-2028 (%)
Exhibits 46: Chart on Comparison by Deployment
Exhibits 47: Data Table on Comparison by Deployment
Exhibits 48: Chart on On-premises - Market size and forecast 2023-2028 ($ billion)
Exhibits 49: Data Table on On-premises - Market size and forecast 2023-2028 ($ billion)
Exhibits 50: Chart on On-premises - Year-over-year growth 2023-2028 (%)
Exhibits 51: Data Table on On-premises - Year-over-year growth 2023-2028 (%)
Exhibits 52: Chart on Cloud - Market size and forecast 2023-2028 ($ billion)
Exhibits 53: Data Table on Cloud - Market size and forecast 2023-2028 ($ billion)
Exhibits 54: Chart on Cloud - Year-over-year growth 2023-2028 (%)
Exhibits 55: Data Table on Cloud - Year-over-year growth 2023-2028 (%)
Exhibits 56: Market opportunity by Deployment ($ billion)
Exhibits 57: Data Table on Market opportunity by Deployment ($ billion)
Exhibits 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 61: Chart on Geographic comparison
Exhibits 62: Data Table on Geographic comparison
Exhibits 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 83: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 84: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits 85: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 86: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 91: Chart on France - Market size and forecast 2023-2028 ($ billion)
Exhibits 92: Data Table on France - Market size and forecast 2023-2028 ($ billion)
Exhibits 93: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 94: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 95: Chart on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 96: Data Table on Japan - Market size and forecast 2023-2028 ($ billion)
Exhibits 97: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 98: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 99: Market opportunity By Geographical Landscape ($ billion)
Exhibits 100: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits 101: Impact of drivers and challenges in 2023 and 2028
Exhibits 102: Overview on Criticality of inputs and Factors of differentiation
Exhibits 103: Overview on factors of disruption
Exhibits 104: Impact of key risks on business
Exhibits 105: Vendors covered
Exhibits 106: Matrix on vendor position and classification
Exhibits 107: ADInstruments Pty Ltd. - Overview
Exhibits 108: ADInstruments Pty Ltd. - Product/Service
Exhibits 109: ADInstruments Pty Ltd. - Key offerings
Exhibits 110: BIOPAC Systems Inc. - Overview
Exhibits 111: BIOPAC Systems Inc. - Product/Service
Exhibits 112: BIOPAC Systems Inc. - Key offerings
Exhibits 113: Bruker Corp. - Overview
Exhibits 114: Bruker Corp. - Business segments
Exhibits 115: Bruker Corp. - Key offerings
Exhibits 116: Bruker Corp. - Segment focus
Exhibits 117: Columbus Instruments LLC - Overview
Exhibits 118: Columbus Instruments LLC - Product/Service
Exhibits 119: Columbus Instruments LLC - Key offerings
Exhibits 120: emka TECHNOLOGIES - Overview
Exhibits 121: emka TECHNOLOGIES - Product/Service
Exhibits 122: emka TECHNOLOGIES - Key offerings
Exhibits 123: ETISENSE SAS - Overview
Exhibits 124: ETISENSE SAS - Product/Service
Exhibits 125: ETISENSE SAS - Key offerings
Exhibits 126: Harvard Bioscience Inc. - Overview
Exhibits 127: Harvard Bioscience Inc. - Product/Service
Exhibits 128: Harvard Bioscience Inc. - Key offerings
Exhibits 129: Instem Plc - Overview
Exhibits 130: Instem Plc - Product/Service
Exhibits 131: Instem Plc - Key offerings
Exhibits 132: Med Associates Inc. - Overview
Exhibits 133: Med Associates Inc. - Product/Service
Exhibits 134: Med Associates Inc. - Key offerings
Exhibits 135: Noldus Information Technology bv - Overview
Exhibits 136: Noldus Information Technology bv - Product/Service
Exhibits 137: Noldus Information Technology bv - Key offerings
Exhibits 138: PerkinElmer Inc - Overview
Exhibits 139: PerkinElmer Inc - Business segments
Exhibits 140: PerkinElmer Inc - Key news
Exhibits 141: PerkinElmer Inc - Key offerings
Exhibits 142: PerkinElmer Inc - Segment focus
Exhibits 143: Starr Life Sciences Corp. - Overview
Exhibits 144: Starr Life Sciences Corp. - Product/Service
Exhibits 145: Starr Life Sciences Corp. - Key offerings
Exhibits 146: Stoelting Co. - Overview
Exhibits 147: Stoelting Co. - Product/Service
Exhibits 148: Stoelting Co. - Key offerings
Exhibits 149: TSE Systems GmbH - Overview
Exhibits 150: TSE Systems GmbH - Product/Service
Exhibits 151: TSE Systems GmbH - Key offerings
Exhibits 152: Xybion Digital Inc. - Overview
Exhibits 153: Xybion Digital Inc. - Key offerings
Exhibits 154: Inclusions checklist
Exhibits 155: Exclusions checklist
Exhibits 156: Currency conversion rates for US$
Exhibits 157: Research methodology
Exhibits 158: Validation techniques employed for market sizing
Exhibits 159: Information sources
Exhibits 160: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global preclinical software for physiology data assessment and animal supervision market: ADInstruments Pty Ltd., BIOPAC Systems Inc., Bruker Corp., Columbus Instruments LLC, emka TECHNOLOGIES, ETISENSE SAS, Harvard Bioscience Inc., Instem Plc, Med Associates Inc., Noldus Information Technology bv, PerkinElmer Inc, Starr Life Sciences Corp., Stoelting Co., Thermo Fisher Scientific Inc., TSE Systems GmbH, UGO BASILE S.R.L., Vanderbilt University Medical Center, Xybion Digital Inc., and Zaber Technologies Inc.

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rising digitalization in preclinical research.'

According to the report, one of the major drivers for this market is the emerging role of bioinformatics tools and software in preclinical research.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape and a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • ADInstruments Pty Ltd.
  • BIOPAC Systems Inc.
  • Bruker Corp.
  • Columbus Instruments LLC
  • emka TECHNOLOGIES
  • ETISENSE SAS
  • Harvard Bioscience Inc.
  • Instem Plc
  • Med Associates Inc.
  • Noldus Information Technology bv
  • PerkinElmer Inc
  • Starr Life Sciences Corp.
  • Stoelting Co.
  • Thermo Fisher Scientific Inc.
  • TSE Systems GmbH
  • UGO BASILE S.R.L.
  • Vanderbilt University Medical Center
  • Xybion Digital Inc.
  • Zaber Technologies Inc.